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A therosclerosis and other vascular inflammatory diseases continue to be a significant health and socioeconomic problem in the Western and developing world. 1 Atherosclerosis is a lipiddriven, chronic vascular inflammatory disease driven and maintained by proinflammatory cytokines secreted by both immune and vascular cells, with most studies focusing on the role of proinflammatory cytokines in activation of macrophages, endothelial cells, and leukocyte subsets in this disease. 2, 3 By comparison, a much smaller number of studies focus on the role of endogenous counter-regulatory mechanisms in atherogenesis and their effects on these same cells and impact on atherosclerosis. Potential protective effects of anti-inflammatory cytokines including T h 2 interleukins on resident vascular (endothelial cell and vascular smooth muscle cell [VSMC] ) and inflammatory cells remain as a gap in our knowledge. Antiatherosclerotic interleukins that can target resident vascular cells, in addition to immune cells, have the potential to reduce localized inflammation of the vascular wall as well as polarize global immunity. Identification of such interleukins can lead to potential therapeutic targets.
We have reported a distinctive role for one such antiinflammatory interleukin, , in vascular disease. [4] [5] [6] IL-19 is a member of an IL-10 subfamily which also includes IL-20, IL-22, and IL-24. 7, 8 IL-19 has unique properties including expression as well as target cells outside of the immune system and NF-κB-independent effects. 9 Although expression of T h 2 cytokines in atherosclerotic plaque is rare, we previously reported that IL-19 is expressed in multiple cell types in atherosclerotic plaque in both humans and mice. 10 We also observed increased IL-19 in symptomatic patients compared with asymptomatic patients. Injection of recombinant IL-19 into atherosclerosis-prone Ldlr −/− (low-density lipoprotein receptor knock out) mice can reduce the severity of atherosclerosis, 10 as well as prevent expansion of existing plaque 11 by multiple effects on adaptive immunity, including polarization of T cells to T h 2 and macrophages to M2 phenotypes, respectively.
In response to proinflammatory stimuli, gene expression in resident vascular and immune cells is regulated by transcriptional and post-transcriptional mechanisms. Factors that control mRNA stability are essential regulators, which allow these cells to rapidly and appropriately respond to environmental cues. The role of mRNA stability proteins in regulation of vascular response to injury, as well as their modification by anti-inflammatory factors represent the second gap in our knowledge on how anti-inflammatory interleukins may be atheroprotective.
IL-19 has inflammation-dampening effects on cultured VSMC and endothelial cell, including reduction of expression of proinflammatory cytokines and adhesion molecules. 5, 9, 12 Collectively, these studies suggest that IL-19 expression in atherosclerotic plaque may be a compensatory, counter-regulatory mechanism to reduce local inflammation. However, an investigation into the absence of IL-19 on the development of atherosclerosis has not been tested or reported.
We hypothesized that genetic deletion of IL-19 would augment atherosclerosis in Ldlr −/− mice. To test this hypothesis, we crossed Il19 −/− mice with Ldlr −/− to create double knockout (dKO) mice. In this study, we report that loss of IL-19 leads to exacerbated atherosclerosis, which can be rescued by treatment with recombinant mouse IL-19 in dKO mice. Further, we report that a potential mechanism for these effects is an increase in proinflammatory gene mRNA stability in bone marrow-derived macrophage (BMDM) and VSMC in dKO mice. IL-19 regulation of mRNA stability may be mediated by miRNA targeting of mRNA stability proteins. From a broader perspective, this study also suggests that mRNA stability proteins may represent targets for novel antiatherosclerotic therapeutics.
Materials and Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request.
A detailed listing of mice and antibodies used are listed in the major resource table in the online-only Data Supplement.
Mouse Studies
Ldlr −/− mice on the C57BL/6 background purchased from Jackson laboratories (Catalog number 002207) were bred with Il19 −/− mice previously described 10, 11 to obtain homozygous Il19 −/− ×Ldlr −/− dKO mice. Mice were housed in an ALAC-approved facility and maintained on a standard chow diet until study commencement. Mice of both sexes were entered in the study at 8 weeks of age when normal chow was replaced with an atherogenic diet (42% fat, 0.2% cholesterol, Harlan atherogenic diet TD.88137). For the rescue study, mice were injected IP with 10 ng/g per day recombinant mouse IL-19 (BioVision, Catalog number 4546) as we have described 10, 11 or an equal volume of PBS, 5 days per week for 14 weeks. Fasting lipid content in mouse sera was analyzed by Charles River Research Animal Diagnostic Services. For adaptive bone marrow transplantation, 8-week-old male and female Ldlr −/− mice were irradiated (950 rads). Bone marrow was isolated from Ldlr −/− and dKO donors as described below and transplanted via single retro-orbital injection (5 million cells/injection). After 4 weeks, mice were administered atherogenic diet for 14 weeks. All animal procedures adhered to approved Temple University Institutional Animal Care and Use Committee approved protocols.
Atherosclerotic Lesion Analysis
Atherosclerotic plaque burden was determined in the aortic intimal surface by en face staining with Sudan IV and in the aortic root by Oil Red O staining as we described. 10, 11 Lesion size in the aortic arch was determined by quantitative morphometry using the Image Pro Plus program. Aortic root was frozen in optimal cutting temperature medium and sectioned. Four transverse serial sections spaced 70 to 100 μm apart from the aortic sinus to disappearance of valve cusps per aortic root were stained with Oil Red O, and positive stained areas quantitated as a percentage of total area by quantitative morphometry.
Cell Culture
Aorta from Ldlr −/− and dKO mice were excised, endothelial layer removed, and VSMC isolated as we described. 6, 12, 13 VSMC were cultured in DMEM supplemented with 20% fetal bovine serum (FBS). Over 95% of isolated cells were SMC actin positive, and VSMC from passage 2 to 4 were used. For BMDM, femurs and tibiae were flushed with sterile PBS, red blood cells were lysed and removed using ACK lysis buffer (ThermoFisher) and cell strainers. Collected cells were resuspended and seeded in DMEM+10% heat-inactivated FBS with 100 ng/mL M-CSF (Peprotech). Cells were cultured for 6 to 7 days until confluent. For gene and protein expression analyses, cells were stimulated with 10 ng/mL TNF (tumor necrosis factor)-α (Sigma). For RNA stability experiments, cells were treated with 10 ng/mL actinomycin D after TNF-α stimulation. Untreated samples were used as controls.
RNA Extraction and Quantitative RT-PCR
RNA from spleen, aortic arch, and cultured cells was isolated using the RNeasy PowerLyzer Tissue & Cells Kit (Qiagen) and Direct-zol RNA Miniprep Plus (Zymo Research) for tissue and cells, respectively, according to the manufacturer's protocol. A full description of RT-PCR is found in the online-only Data Supplement.
Western Blotting
Protein extracts made as described were separated by SDS-PAGE, transferred to nitrocellulose membrane, incubated with a 1:3000 dilution of primary antibody HuR or TNF-α (Abcam, Santa Cruz Biotechnology), followed by a 1:4000 dilution of secondary antibody. 4, 6, 9, 10, 12 A full description of Western blotting is found in the online-only Data Supplement.
Immunohistochemistry
Aortic roots were frozen in optimal cutting temperature and 5 µm-thick serial sections were cut and placed on microscope slides. 4, 9, 10, 12, 13 A full description of the immunohistochemical methodology is found in the online-only Data Supplement. 
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Statistical Analysis
Results are expressed as mean±SEM. A full description of statistical analysis is found in the online-only Data Supplement. Figure 1C and 1D). There was no significant difference in lesion area between sexes in either group. There was also no significant difference in lipid profile (cholesterol: 2155±325.9 mg/dL in Ldlr −/− versus 2044±487 mg/dL in dKO; triglyceride: 925.4±243 mg/dL in Ldlr −/− versus 1022±392.2 mg/dL in dKO; Figure 1E ) or weight gain during the course of the study (6.033±1.5 g in Ldlr −/− versus 5.346±1.2 g in dKO; Figure 1F ; Figure I in the online-only Data Supplement). Together these data suggest that absence of IL-19 results in increased severity of atherosclerosis.
Results
Il19
Recombinant IL-19 Treatment Rescues dKO Atherosclerotic Phenotype
To confirm the role of IL-19 in atherogenesis and to demonstrate the specificity of IL-19, dKO mice were administered daily IP injections of recombinant mouse IL-19 (10 ng/g per day), or an equivalent volume of phosphate buffered saline while simultaneously being fed HFD for 14 weeks. En face staining of aorta shows that dKO mice injected with IL-19 had significantly less plaque burden compared with dKO mice injected with saline (23.89±3.8% in PBS injected versus 11.72±1.1% in IL-19 injected; P<0.01; Figure 1G and 1H). As in the previous experiment, there were no significant differences in serum lipid profile or weight gain between IL-19 and saline-injected mice. Because the addition of IL-19 to dKO mice can rescue, or decrease atherosclerosis burden, these data demonstrate IL-19 specificity and suggest that IL-19 can regulate development of atherosclerosis.
Loss of IL-19 Influences Global and Local Inflammatory Responses
The development and severity of atherosclerosis is influenced by systemic adaptive immunity as well as local adaptive immunity within the plaque. To determine whether loss of IL-19 had systemic and local effects on the adaptive immune response, spleen and aorta were harvested from Ldlr −/− and dKO mice after 14 weeks of HFD feeding, at the time of euthanasia. Markers associated with T cell and macrophage polarity were quantitated by qRT-PCR. Figure 2A shows significantly increased levels of mRNA of several proinflammatory markers in dKO spleen, including TNF-α, TBet, IL-12β, and IL-1β, suggesting a globally polarized T h 1, M1 profile in dKO mice. Correspondingly, there was significantly decreased expression of Tregs marker, FOXP3, and anti-inflammatory cytokine, IL-10 in spleen from dKO mice. There were no significant differences in GATA3, Arg2, or Arg1 mRNA in spleen between dKO and control mice, suggesting no differences in T h 2 or M2 populations in spleen ( Figure II in the online-only Data Supplement). Similarly, Figure 2C displays significantly increased TNF-α, TBet, Arg2, IL-12β, IL-1β, MCP-1, and RORγ mRNA abundance in the aortic arch from dKO compared with Ldlr −/− mice, indicating an immune profile within the plaque polarized to T h 1, T h 17, and M1. Interestingly, an abundance of T h 2 marker, GATA3, and IL-10 mRNA were significantly decreased in the aortic arch of dKO mice. Despite differences in macrophage polarization, no significant difference was noted in a total number of infiltrating macrophages in the atherosclerotic lesions of dKO mice compared with control mice ( Figure IV in the online-only Data Supplement).
Treatment of dKO mice with IL-19 was able to rescue the immune cell profile in the spleen, as Figure 2B shows significantly decreased levels of TNF-α, TBet, IL-12β, and IL-1β mRNA, as well as significantly increased FOXP3 and IL-10 mRNA when compared with dKO mice treated with saline. Figure 2D shows that aortic arch from dKO mice treated with IL-19 has significantly decreased TNF-α, TBet, Arg2, IL-12β, MCP-1, RORγ, and IL-1β mRNA, and significantly greater levels of GATA3 and IL-10 mRNA compared with PBS injected control mice. When taken together, this data suggests that mice receiving IL-19 treatment have decreased T h 1, T h 17, and M1 associated gene expression both systemically and locally, compared with saline-treated controls, and suggests that differences in plaque severity in dKO mice compared with Ldlr −/− controls may be mediated by both systemic and intraplaque polarization of adaptive immunity. Raw numbers for all qRT-PCR are shown in Tables I and II in 
Immune Cells Participate in IL-19 Antiatherosclerotic Effects
IL-19 has confirmed immunoregulatory effects, and it was important to determine the major effector cell of IL-19 
Loss of IL-19 Increases TNF-α Expression and Stability in BMDM and VSMC
TNF-α is a potent proinflammatory cytokine that participates in atherogenesis.
14 TNF-α protein abundance was significantly elevated in the spleen of dKO mice after 14 weeks of HFD compared with Ldlr −/− control mice (838±56 AU in Ldlr −/− versus 1276±20 AU in dKO; P<0.001; Figure 3C and 3D). Similarly, TNF-α protein was increased in the aortic arch of dKO mice compared with Ldlr −/− control mice (630.7±107 AU in Ldlr −/− versus 1471±221 AU in dKO; P<0.05; Figure 3E and 3F). These data suggest dKO mice have both a global and local increase in proinflammatory TNF-α expression.
To determine the molecular mechanisms that may be responsible for the increased abundance of TNF-α in dKO mice, we isolated BMDM and VSMC from Ldlr −/− and dKO mice. BMDM and VSMC were cultured and stimulated with TNF-α, a potent proinflammatory stimulus. Both BMDM and VSMC from dKO mice expressed significantly increased amounts of TNF-α mRNA compared with Figure 4A and 4G). To further define a mechanism, this experiment was repeated with the addition of the transcription inhibitor actinomycin D after TNF-α stimulation. TNF-α mRNA was significantly more stable in cells isolated from dKO mice compared with Ldlr −/− control mice ( Figure 4B and 4H) . To confirm the specificity of IL-19 in regulating TNF-α mRNA stability, we next attempted to rescue increased TNF-α mRNA stability in dKO cells by pretreating them with IL-19. Pretreatment with IL-19, before TNF-α stimulation in dKO BMDM and VSMC significantly decreases TNF-α mRNA stability when compared with control dKO cells ( Figure 4C and 4I) . We examined mRNA transcripts of additional proinflammatory cytokines known to participate in atherogenesis and also regulated by IL-19. Similar results were obtained with IL-1β in BMDM, and MCP-1 in VSMC ( Figure 4E , 4F, 4K, and 4L, respectively). These data suggest that IL-19 can control proinflammatory cytokine abundance in BMDM and VSMC by regulation of mRNA stability.
HuR Is Elevated in Mice Lacking IL-19
Regulation of mRNA stability is an important post-transcriptional mechanism of controlling inflammatory cytokine abundance. HuR (human antigen R) is an important regulator of TNF-α mRNA stability, 15, 16 and because IL-19 treatment resulted in decreased proinflammatory cytokine mRNA stability, several experiments were performed to draw a relationship between IL-19 expression and HuR abundance. First, we determined if HuR is expressed in murine atherosclerotic plaque. Immunohistochemical localization shows that HuR is expressed more robustly in the area of the plaque, rather than in the media, distal from the plaque. Dual-color immunohistochemistry using lineage-specific antibody shows that HuR expression is similar to from dKO mice stimulated with TNF-α express significantly increased HuR protein levels compared with BMDM from Ldlr −/− mice ( Figure 5G and 5H) . Interestingly, unstimulated BMDM from dKO express significantly higher basal levels of TNF-α compared with BMDM from Ldlr −/− . Similarly, VSMC explanted from dKO also express significantly greater levels of HuR under basal conditions, as well as after TNF-α stimulation when compared with Ldlr −/− VSMC ( Figure 5I and 5J). These data suggest that absence of IL-19 is associated with an increase in HuR mRNA and protein abundance.
IL-19 Treatment Reduces HuR mRNA Stability
We utilized BMDM and VSMC explanted from Ldlr −/− and dKO mice to determine a mechanism for the observed effect of IL-19 on HuR abundance. Using actinomycin D, we observed significantly increased stability of HuR mRNA in both BMDM and VSMC from dKO mice compared with Ldlr −/− controls ( Figure 6A and 6D) . We next added recombinant mouse IL-19 to dKO cells to rescue HuR mRNA stability. Figure 6B and 6E show that treatment with IL-19 to dKO BMDM and VSMC significantly decreases HuR mRNA stability in the dKO cells, compared with control cells that were not treated with IL-19. Proliferating cell nuclear antigen, which lacks AU-rich elements (AREs) in its 3′ untranslated region (UTR) served as a negative control and Figure 6E and 6F demonstrate no difference in proliferating cell nuclear antigen mRNA stability between Ldlr −/− and dKO BMDM and VSMC. Together, these data strongly suggest that IL-19 can decrease HuR mRNA stability, and the increase in HuR noted in dKO mice and cells isolated from dKO mice is likely because of loss of IL-19.
It was important to determine a more detailed mechanism of how IL-19 might decrease HuR mRNA stability. We previously described that IL-19-induced expression of miR133a, a muscle-specific miRNA, in human VSMC. 17 In searching a public database (http://www.targetscan.org) one predicted target for miR133a is HuR 3′UTR (Data VIA in the online-only Data Supplement). To determine whether this was a mechanism for differences in HuR abundance, we found that dKO VSMC expressed significantly less miR133a compared with Ldlr −/− control VSMC. miR133a expression trended lower in dKO compared with control aorta (Data VIB in the onlineonly Data Supplement). Importantly, miR133a expression could be induced or rescued in dKO VSMC by the addition of IL-19 ( Figure 6G ). Figure 6H shows that transfection of miR133a significantly reduced HuR mRNA abundance in hVSMC, and Figure 6H validates this at the protein level, suggesting that one potential mechanism for the IL-19 reduction in HuR abundance is mediated by miR133a expression.
Discussion
The major finding from this study is that the absence of the anti-inflammatory cytokine IL-19 results in increased atherosclerosis, which can be reversed by injection of recombinant mouse IL-19 into the Il19 −/− x Ldlr −/− dKO mice. T h 1 interleukins are considered to be proinflammatory and proatherogenic, and in general, T h 2 interleukins are proposed to be antiatherogenic. 14, [18] [19] [20] Thus, alteration in the balance of these interleukins could potentially affect the development and severity of atherosclerosis. Previous studies led us to hypothesize that IL-19 may represent a counter-regulatory mechanism to reduce local inflammation. The present study showed increased systemic and intraplaque expression of the proinflammatory cytokine TNF-α in Ldlr −/− mice lacking IL-19. Importantly, injection of IL-19 into dKO mice significantly reduced plaque burden to levels comparable to Ldlr −/− mice, confirming atheroprotective effects and validating the specificity of IL-19 in this system.
Genetic deletion of the archetypal T h 2 interleukin IL-10 also reduces atherosclerosis formation in several studies, 21, 22 but there are some notable differences from loss of IL-19. In Il10 −/− mice crossed into the ApoE background, total cholesterol was higher in the dKO mice, where in our study no difference in cholesterol between Ldlr −/− and dKO was noted. 22, 23 In both of these cases, authors concluded that protection was because of adaptive immune modulation. TNF-α is considered to be a master inflammatory cytokine as it induces expression of multiple proinflammatory genes. 24 A significantly greater amount of circulating TNF-α+ CD4+ T cells in dKO compared with Ldlr −/− mice following 14 weeks of HFD consumption suggested systemic effects of IL-19. This was confirmed as spleen from dKO mice had increased expression of TNF-α mRNA and protein, and TBet expression was increased in the dKO spleen compared with Ldlr −/− . Differences in intraplaque gene expression were more pronounced than systemic differences; in addition to an increased TBet expression which was seen in spleen, GATA3 was reduced and Arg2 was increased within the aortic arch, indicating a local reduction in T h 2 T cells and an increase in proinflammatory M1 macrophages. Importantly, aortic arch from dKO mice had a significantly greater expression of TNF-α protein compared with controls. The antiatherosclerotic effects of IL-19 are unique in that they seem to be both indirect and direct by affecting adaptive immune responses and by dampening inflammation in macrophages and VSMCs within the plaque area. It was interesting to note that there was less IL-10 mRNA expression in dKO aortic arch compared with controls. This may be a direct effect of loss of IL-19 and an additional cause for exacerbated plaque size; decreased levels of IL-10 can be considered to be a contributing factor, as IL-10 has antiatherosclerotic effects. 22, 23 Concordant with that observed for Ldlr −/− and dKO mice, the immune cell profile in the aortic arch of dKO mice rescued with IL-19 resembled that of Ldlr −/− mice, demonstrating localized anti-inflammatory effects of IL-19.
With this in mind, it was important to determine whether IL-19 antiatherosclerotic effects were mediated by the polarization of adaptive immunity or by direct anti-inflammatory effects on resident vascular cells. Transplantation of dKO BM into Ldlr −/− mice results in significantly increased plaque size compared with control BM. This confirms that at least some of IL-19 atheroprotective effects are mediated by immune cells. This is not surprising as IL-19 is a Th2 interleukin with confirmed immunomodulatory activity. [25] [26] [27] [28] When taken together, IL-19 antiatherosclerotic effects are likely both indirect, by effecting adaptive immune responses, and direct, by dampening inflammation in macrophages and VSMCs within the plaque area.
An additional feature distinguishing IL-19 from IL-10 and IL-33 is that IL-19 is expressed in VSMC as well as immune cells; how the absence of IL-19 affects the response of these cells to inflammatory stimuli has not been reported. We explanted BMDM and VSMC from dKO and Ldlr −/− mice to closely characterize the inflammatory response in each. In both cell types, the cells lacking IL-19 had an increased inflammatory response to TNF-α stimulation. More detailed analysis determined that loss of IL-19 resulted in increased proinflammatory cytokine mRNA stability, which could be reversed, or rescued by addition of IL-19 to dKO BMDM and VSMC. Although this does not rule out transcriptional effects, it does reveal that one mechanism for IL-19 antiinflammatory activity takes place post-transcriptionally. Reduction of proinflammatory cytokine mRNA stability by IL-19 is consistent with our hypothesis that IL-19 acts as a compensatory, negative regulatory factor in response to inflammatory stimuli.
TNF-α is an example of a potent, rapid-response proinflammatory cytokine whose mRNA stability is post-transcriptionally regulated by RBPs (mRNA binding proteins), allowing the cell to tightly regulated induction of other cytokines. 29 Many proinflammatory cytokines, especially TNF-α, have unstable mRNAs, often because of the presence of cis-acting AREs in the 3′UTR which promote degradation. 30 Trans-acting factors including RBPs bind the AREs and regulate mRNA fate. HuR has been shown to recognize and bind the AREs of many cytokine transcripts, including TNF-α, 30, 31 and seems to be the only identified RBP confirmed to stabilize, rather than destabilize, TNF-α transcripts.
HuR expression is increased in neointimal hyperplasia, 32 and induces VSMC constriction. 33 One report suggests that HuR is targeted by IL-10. 34 This study showed that HuR is expressed in an endothelial cell, VSMC, and macrophage in atherosclerotic plaque. We have previously reported that IL-19 affects HuR activity in cultured human VSMC. 9 However, a role for HuR in the mediation of IL-19 antiatherosclerotic activity in vivo are lacking. The present study extends those reports and demonstrates that compared with control mice, the absence of IL-19 significantly increases HuR mRNA and protein abundance systemically, in the spleen, and locally in the aortic arch. Further, cultured BMDM and VSMC isolated from dKO mice demonstrate increased amounts of HuR protein relative to cells cultured from Ldlr −/− mice. It was important to determine how IL-19 modifies HuR abundance. HuR mRNA contains conserved and semi-conserved ARE in its 3′UTR and is reported to regulate its own mRNA stability in a feedback mechanism. 35 We used cultured BMDM and VSMC treated with actinomycin D to determine that the absence of IL-19 results in an increase in HuR mRNA stability in both cell types. Notably, treatment with IL-19 in dKO cells rescued the phenotype, significantly reducing HuR mRNA stability below knock out levels, which may explain the increased HuR protein abundance in spleen and aortic arch in dKO mice. A consistent increase in HuR levels over the 14-week course of our study may lead to greater stability of proinflammatory transcripts and thus, exacerbated inflammation and plaque formation. It is important to note that there were no differences in the stability of proliferating cell nuclear antigen mRNA, which lacks AREs in its 3′UTR. This further supports the notion that increased stability of TNF-α mRNA in dKO cells is because of ARE-dependent stabilization of transcripts by excess HuR.
One mechanism of miRNA function is a reduction of mRNA abundance and subsequent reduction in protein.
Stimulation with IL-19 induces expression of miRNA133a, a muscle cell-specific miRNA.
36 miR133a is predicted to target HuR 3′UTR, and this study showed that miR133a could reduce HuR mRNA and protein abundance. Importantly, miR133a expression was barely detectible in dKO VSMC but could be rescued to Ldlr −/− control levels with the addition of IL-19, providing a potential mechanism for IL-19 reduction of HuR. This may also explain the increased IL-19 sensitivity of VSMC compared with BMDM in terms of reduction of HuR mRNA stability ( Figure 6D ). One limitation of this study is that we cannot experimentally determine whether mRNA stability is modified in dKO mice because RNA transcription inhibitors including actinomycin D are toxic and cannot be used in vivo. However, considering the well-documented role of HuR as an mRNA stability protein together with its increased expression in spleen, aortic arch, and cells explanted from dKO mice, we feel confident that one major mechanism for IL-19 mediated atheroprotective effects is its ability to decrease HuR mRNA abundance, leading to decreases in mRNA stability of proinflammatory cytokines.
The regulation of mRNA stability and translation are 2 levels of post-transcriptional regulation that permit cells to rapidly respond to inflammatory stimuli. 31 Although modulation of mRNA stability has been posited as a possible therapeutic strategy, 37 surprisingly, there is very little literature exploring the concept of RBPs and mRNA stability being directly regulated by inflammatory stimuli. In conclusion, this article demonstrates that lack of IL-19 leads to increased atherosclerosis. This is likely because of increased mRNA stability of proinflammatory cytokines because of increased abundance of the mRNA stability protein, HuR. In the larger picture, it suggests that RBPs may represent a novel class of targets for modalities to attenuate vascular inflammation.
